Federated Hermes’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.28K | Sell |
902
-2,040
| -69% | -$2.9K | ﹤0.01% | 1984 |
|
|
2025
Q1 | $4.5K | Sell |
2,942
-1,350
| -31% | -$2.07K | ﹤0.01% | 1885 |
|
|
2024
Q4 | $10.6K | Sell |
4,292
-9,506
| -69% | -$23.6K | ﹤0.01% | 1834 |
|
|
2024
Q3 | $15.9K | Buy |
13,798
+4,259
| +45% | +$4.9K | ﹤0.01% | 1767 |
|
|
2024
Q2 | $10.5K | Buy |
9,539
+1,280
| +15% | +$1.41K | ﹤0.01% | 1772 |
|
|
2024
Q1 | $10.2K | Buy |
8,259
+3,676
| +80% | +$4.56K | ﹤0.01% | 1774 |
|
|
2023
Q4 | $4.81K | Buy |
+4,583
| New | +$4.81K | ﹤0.01% | 1859 |
|
|
2021
Q2 | – | Sell |
-291
| Closed | -$7K | – | 2193 |
|
|
2021
Q1 | $7K | Sell |
291
-1,043
| -78% | -$25.1K | ﹤0.01% | 2032 |
|
|
2020
Q4 | $9K | Sell |
1,334
-1,044
| -44% | -$7.04K | ﹤0.01% | 1991 |
|
|
2020
Q3 | $6K | Sell |
2,378
-149
| -6% | -$376 | ﹤0.01% | 2007 |
|
|
2020
Q2 | $4K | Buy |
2,527
+2,248
| +806% | +$3.56K | ﹤0.01% | 2011 |
|
|
2020
Q1 | $1K | Buy |
+279
| New | +$1K | ﹤0.01% | 2064 |
|